Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Salix Pharmaceuticals Company Profile (NASDAQ:SLXP)

Consensus Ratings for Salix Pharmaceuticals (NASDAQ:SLXP) (?)
Ratings Breakdown: 1 Sell Rating(s), 5 Hold Rating(s), 7 Buy Rating(s)
Consensus Rating:Hold (Score: 2.46)
Consensus Price Target: $99.87 1.18% downside)

Current Analysts' Coverage Summary for Salix Pharmaceuticals (NASDAQ:SLXP)
Show:
DateFirmActionRatingPrice TargetDetailsShare
4/16/2014Sterne AgeeInitiated CoverageBuy$126.00ViewTweet This Rating  Share This Rating on StockTwits
3/18/2014National Alliance SecuritiesInitiated CoverageBuy$134.62ViewTweet This Rating  Share This Rating on StockTwits
2/28/2014UBS AGBoost Price TargetNeutral$94.00 -> $110.00ViewTweet This Rating  Share This Rating on StockTwits
2/28/2014MizuhoBoost Price Target$127.00 -> $131.00ViewTweet This Rating  Share This Rating on StockTwits
2/28/2014Leerink SwannBoost Price Target$115.00 -> $126.00ViewTweet This Rating  Share This Rating on StockTwits
2/28/2014Piper JaffrayBoost Price Target$106.00 -> $127.00ViewTweet This Rating  Share This Rating on StockTwits
2/28/2014Brean CapitalBoost Price Target$108.00 -> $125.00ViewTweet This Rating  Share This Rating on StockTwits
2/7/2014Roth CapitalBoost Price Target$106.00 -> $110.00ViewTweet This Rating  Share This Rating on StockTwits
1/20/2014ZacksReiterated RatingNeutral -> Neutral$103.00ViewTweet This Rating  Share This Rating on StockTwits
1/7/2014Bank of AmericaDowngradeUnderperformViewTweet This Rating  Share This Rating on StockTwits
12/17/2013Stifel NicolausUpgradeHold -> Buy$108.00ViewTweet This Rating  Share This Rating on StockTwits
11/19/2013Janney Montgomery ScottReiterated RatingBuy$95.00ViewTweet This Rating  Share This Rating on StockTwits
11/11/2013SusquehannaBoost Price Target$75.00 -> $81.00ViewTweet This Rating  Share This Rating on StockTwits
11/11/2013Cantor FitzgeraldBoost Price TargetHold$77.00 -> $80.00ViewTweet This Rating  Share This Rating on StockTwits
9/17/2013Goldman SachsInitiated CoverageNeutral$73.00ViewTweet This Rating  Share This Rating on StockTwits
6/12/2013Buckingham ResearchUpgradeNeutral -> Buy$53.00 -> $90.00ViewTweet This Rating  Share This Rating on StockTwits
6/7/2013Jefferies GroupReiterated RatingBuy$70.00ViewTweet This Rating  Share This Rating on StockTwits
5/28/2013RBC CapitalReiterated RatingBuy$60.00ViewTweet This Rating  Share This Rating on StockTwits
5/13/2013WallachBeth CapitalBoost Price TargetHold$45.00 -> $48.00ViewTweet This Rating  Share This Rating on StockTwits
7/30/2012ThinkEquityDowngradeBuy -> Hold$53.00ViewTweet This Rating  Share This Rating on StockTwits
7/30/2012Wells Fargo & Co.Reiterated RatingOutperform -> BuyViewTweet This Rating  Share This Rating on StockTwits
5/8/2012AurigaReiterated RatingHoldViewTweet This Rating  Share This Rating on StockTwits
(Data available from 4/19/2012 forward)